US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

32.52

-1.7300-5.05%

Post-market: 32.19-0.3300-1.01%19:57 EDT

Volume:2.25M

Turnover:73.93M

Market Cap:3.76B

PE:-10.19

High:34.25

Open:33.99

Low:32.30

Close:34.25

52wk High:43.15

52wk Low:18.92

Shares:115.55M

Float Shares:110.00M

Volume Ratio:0.90

T/O Rate:2.05%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.1920

EPS(LYR):-3.1920

ROE:-47.34%

ROA:-30.27%

PB:5.88

PE(LYR):-10.19

Loading ...

Overview Company News Filings

Obesity Drugmakers and Developers Fall After Rival Novo Nordisk Warns of Steep 2026 Sales Decline

THOMSON REUTERS

Structure Therapeutics Down 5.3%, Viking Therapeutics Down 3.3%, Amgen Down 1.4%

THOMSON REUTERS

Viking Therapeutics stellt neue klinische Fortschritte bei Medikamenten gegen Adipositas und Stoffwechselkrankheiten vor

Analysts Are Bullish on Top Healthcare Stocks: GH Research (GHRS), Viking Therapeutics (VKTX)

Viking Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Chief Commercial Officer Neil William Aubuchon

Viking Therapeutics Showcases Advancements in Obesity and Metabolic Disease Pipeline in New Corporate Presentation

Appetite for weight-loss deals broader than visible, Viking CEO says

Viking Therapeutics Reports Phase 2 Trial Shows VK2735 Achieves Up to 14.7% Weight Loss in Obesity Patients

Viking Therapeutics Announces Publication of Results From Phase 2 Venture Trial of Dual Glp-1/Gip Receptor Agonist Vk2735 in the Journal Obesity

THOMSON REUTERS

Viking Therapeutics (VKTX) Receives a Buy from Maxim Group

Viking Therapeutics: Timely VK2735 Clinical Progress and Flexible Dosing Drive Favorable Risk‑Reward and Buy Rating

Positioning Viking Therapeutics’ VK2735 as a Differentiated, Best-in-Class Obesity Franchise with Compelling Monthly Maintenance Potential Supporting a Buy Rating

Viking Therapeutics Completes Enrollment for VK2735 Obesity Maintenance Dosing Study

Viking Therapeutics Announces Completion of Enrollment in Maintenance Dosing Clinical Trial of Vk2735 in Obesity

THOMSON REUTERS

Will Viking Therapeutics’ New CCO Reframe VKTX’s Obesity Strategy Amid Intensifying GLP-1 Competition?

Simply Wall St.

Weight-Loss Drugmakers' Stocks Jump. Structure Therapeutics up 5%; Eli Lilly Rises 4% to Record High; Amgen up 3%; Roche, Novo up Around 2%

Tiger Newspress

Press Release: Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer

Weight-Loss Drugmakers' Stocks Jump. Arrowhead up over 17%; Structure Therapeutics up over 6%; Novo Nordisk up 5%; Viking, Pfizer, Eli Lilly up Around 2%

Tiger Newspress

12 Days of Christmas? 12 Stocks That Are Gifts for 2026

FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats up

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VKTX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"VKTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VKTX\",,,,,undefined,":{"symbol":"VKTX","market":"US","secType":"STK","nameCN":"Viking Therapeutics","latestPrice":32.52,"timestamp":1774641600000,"preClose":34.25,"halted":0,"volume":2251552,"hourTrading":{"tag":"盘后","latestPrice":32.19,"preClose":32.52,"latestTime":"19:57 EDT","volume":54209,"amount":1761154.7484,"timestamp":1774655828402,"change":-0.33,"changeRate":-0.010148,"amplitude":0.0123},"delay":0,"changeRate":-0.0505109489051094,"floatShares":110000000,"shares":115554295,"eps":-3.192044,"marketStatus":"Market Closed","change":-1.73,"latestTime":"03-27 16:00:00 EDT","open":33.99,"high":34.2491,"low":32.3012,"amount":73925490.511552,"amplitude":0.056873,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.192044,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1430280000000,"exchange":"NASDAQ","adjPreClose":34.25,"preHourTrading":{"tag":"盘前","latestPrice":33.9,"preClose":34.25,"latestTime":"09:29 EDT","volume":5195,"amount":175519.6207,"timestamp":1774618197083,"change":-0.35,"changeRate":-0.010219,"amplitude":0.02073},"postHourTrading":{"tag":"盘后","latestPrice":32.19,"preClose":32.52,"latestTime":"19:57 EDT","volume":54209,"amount":1761154.7484,"timestamp":1774655828402,"change":-0.33,"changeRate":-0.010148,"amplitude":0.0123},"volumeRatio":0.896016,"impliedVol":0.7656,"impliedVolPercentile":0.2311},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VKTX\",,,,,undefined,":{"symbol":"VKTX","floatShares":110000000,"roa":"-30.27%","roe":"-47.34%","lyrEps":-3.192044,"volumeRatio":0.896016,"shares":115554295,"dividePrice":0,"high":34.2491,"amplitude":0.056873,"preClose":34.25,"low":32.3012,"week52Low":18.92,"pbRate":"5.88","week52High":43.15,"institutionHeld":0,"latestPrice":32.52,"eps":-3.192044,"divideRate":0,"volume":2251552,"delay":0,"ttmEps":-3.192044,"open":33.99,"prevYearClose":35.18,"prevWeekClose":32.33,"prevMonthClose":33.84,"prevQuarterClose":35.18,"fiveDayClose":32.33,"twentyDayClose":33.84,"sixtyDayClose":35.32},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VKTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-11","symbol":"VKTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.89,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1770786000000,"reportTimeType":"post","actualEps":-1.38},{"market":"US","date":"2025-10-22","symbol":"VKTX","fiscalQuarterEnding":"2025/09","expectedEps":-0.7,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1761105600000,"reportTimeType":"post","actualEps":-0.81},{"market":"US","date":"2025-07-23","symbol":"VKTX","fiscalQuarterEnding":"2025/06","expectedEps":-0.44,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1753243200000,"reportTimeType":"post","actualEps":-0.58},{"market":"US","date":"2025-04-23","symbol":"VKTX","fiscalQuarterEnding":"2025/03","expectedEps":-0.34,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1745380800000,"reportTimeType":"post","actualEps":-0.41},{"market":"US","date":"2025-02-05","symbol":"VKTX","fiscalQuarterEnding":"2024/12","expectedEps":-0.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738731600000,"reportTimeType":"post","actualEps":-0.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VKTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VKTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3684,"buy":0.5263,"hold":0.1053,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5263,"analysts":19,"updateTime":1774584000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VKTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VKTX","date":"2026-03-27","current":-10.187829,"percent":0.638911,"low":-119.243765,"twenty":-33.836797,"median":-16.606487,"eighty":-7.096069,"high":-2.86002,"avg":-25.08626,"sd":24.208667,"marketCap":3957734603},"quantilePoints":[{"date":"2021-04-01","current":-11.78772,"twenty":-25.399289,"median":-13.536713,"eighty":-1.667605,"marketCap":465555999},{"date":"2021-04-09","current":-11.568407,"twenty":-25.411586,"median":-13.537772,"eighty":-1.683821,"marketCap":456894239},{"date":"2021-04-16","current":-11.470701,"twenty":-25.411586,"median":-13.537772,"eighty":-1.69996,"marketCap":453035335},{"date":"2021-04-23","current":-11.763819,"twenty":-25.411586,"median":-13.537772,"eighty":-1.716245,"marketCap":464612047},{"date":"2021-04-30","current":-11.389385,"twenty":-25.399289,"median":-13.536713,"eighty":-1.728163,"marketCap":499060073},{"date":"2021-05-07","current":-10.516021,"twenty":-25.399289,"median":-13.536713,"eighty":-1.748072,"marketCap":460790991},{"date":"2021-05-14","current":-10.997262,"twenty":-25.399289,"median":-13.536713,"eighty":-1.764364,"marketCap":481878036},{"date":"2021-05-21","current":-10.676434,"twenty":-25.399289,"median":-13.536713,"eighty":-1.780463,"marketCap":467820006},{"date":"2021-05-28","current":-9.339652,"twenty":-25.399289,"median":-13.536713,"eighty":-1.785641,"marketCap":409244880},{"date":"2021-06-04","current":-9.3753,"twenty":-25.399289,"median":-13.536713,"eighty":-1.828278,"marketCap":410806883},{"date":"2021-06-11","current":-10.836848,"twenty":-25.399289,"median":-13.536713,"eighty":-1.8479,"marketCap":474849021},{"date":"2021-06-18","current":-10.943791,"twenty":-25.399289,"median":-13.536713,"eighty":-1.882568,"marketCap":479535031},{"date":"2021-06-25","current":-11.995393,"twenty":-25.399289,"median":-13.536713,"eighty":-1.943791,"marketCap":525614130},{"date":"2021-07-02","current":-11.03291,"twenty":-25.399289,"median":-13.536713,"eighty":-1.966643,"marketCap":483440039},{"date":"2021-07-09","current":-10.997262,"twenty":-25.399289,"median":-13.536713,"eighty":-1.977985,"marketCap":481878036},{"date":"2021-07-16","current":-10.409078,"twenty":-25.399289,"median":-13.536713,"eighty":-2.013559,"marketCap":456104981},{"date":"2021-07-23","current":-10.284312,"twenty":-25.399289,"median":-13.536713,"eighty":-2.028597,"marketCap":450637969},{"date":"2021-07-30","current":-9.689632,"twenty":-25.399289,"median":-13.536713,"eighty":-2.052782,"marketCap":480867356},{"date":"2021-08-06","current":-9.642365,"twenty":-25.399289,"median":-13.536713,"eighty":-2.068819,"marketCap":478521661},{"date":"2021-08-13","current":-9.3115,"twenty":-25.399289,"median":-13.536713,"eighty":-2.079369,"marketCap":462101800},{"date":"2021-08-20","current":-9.138189,"twenty":-25.399289,"median":-13.536713,"eighty":-2.084856,"marketCap":453500921},{"date":"2021-08-27","current":-9.815676,"twenty":-25.399289,"median":-13.536713,"eighty":-2.100894,"marketCap":487122541},{"date":"2021-09-03","current":-10.713739,"twenty":-25.399289,"median":-13.536713,"eighty":-2.116931,"marketCap":531690735},{"date":"2021-09-10","current":-10.398629,"twenty":-25.399289,"median":-13.536713,"eighty":-2.137786,"marketCap":516052772},{"date":"2021-09-17","current":-10.540429,"twenty":-25.399289,"median":-13.536713,"eighty":-2.248379,"marketCap":523089855},{"date":"2021-09-24","current":-10.209563,"twenty":-25.399289,"median":-13.536713,"eighty":-2.477122,"marketCap":506669994},{"date":"2021-10-01","current":-9.673876,"twenty":-25.399289,"median":-13.536713,"eighty":-3.066451,"marketCap":480085457},{"date":"2021-10-08","current":-9.48481,"twenty":-25.386992,"median":-13.535653,"eighty":-3.422547,"marketCap":470702680},{"date":"2021-10-15","current":-9.469055,"twenty":-25.386992,"median":-13.535653,"eighty":-3.746445,"marketCap":469920782},{"date":"2021-10-22","current":-9.075167,"twenty":-25.386992,"median":-13.535653,"eighty":-3.931498,"marketCap":450373328},{"date":"2021-10-29","current":-9.1697,"twenty":-25.386992,"median":-13.535653,"eighty":-4.134737,"marketCap":455064717},{"date":"2021-11-05","current":-9.53443,"twenty":-25.386992,"median":-13.535653,"eighty":-4.513878,"marketCap":510873825},{"date":"2021-11-12","current":-8.979593,"twenty":-25.386992,"median":-13.535653,"eighty":-4.798493,"marketCap":481144567},{"date":"2021-11-19","current":-8.234944,"twenty":-25.386992,"median":-13.535653,"eighty":-4.900663,"marketCap":441244773},{"date":"2021-11-26","current":-7.855319,"twenty":-25.386992,"median":-13.535653,"eighty":-5.011337,"marketCap":420903702},{"date":"2021-12-03","current":-7.169074,"twenty":-25.386992,"median":-13.535653,"eighty":-5.341054,"marketCap":384133304},{"date":"2021-12-10","current":-7.081468,"twenty":-25.386992,"median":-13.535653,"eighty":-7.300482,"marketCap":379439211},{"date":"2021-12-17","current":-7.169074,"twenty":-25.386992,"median":-13.535653,"eighty":-7.300482,"marketCap":384133304},{"date":"2021-12-23","current":-7.5633,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":405256725},{"date":"2021-12-31","current":-6.716444,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":359880489},{"date":"2022-01-07","current":-6.132405,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":328586533},{"date":"2022-01-14","current":-6.190809,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":331715929},{"date":"2022-01-21","current":-5.562968,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":298074927},{"date":"2022-01-28","current":-5.227145,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":280080902},{"date":"2022-02-04","current":-5.183342,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":277733855},{"date":"2022-02-11","current":-5.529152,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":304048067},{"date":"2022-02-18","current":-4.845133,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":266433873},{"date":"2022-02-25","current":-4.887884,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":268784760},{"date":"2022-03-04","current":-4.531625,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":249194034},{"date":"2022-03-11","current":-4.531625,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":249194034},{"date":"2022-03-18","current":-4.802382,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":264082986},{"date":"2022-03-25","current":-4.474623,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":246059518},{"date":"2022-04-01","current":-4.460373,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":245275889},{"date":"2022-04-08","current":-4.132614,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":227252421},{"date":"2022-04-14","current":-3.933108,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":216281615},{"date":"2022-04-22","current":-3.420094,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":188070969},{"date":"2022-04-29","current":-3.225994,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":184149434},{"date":"2022-05-06","current":-3.158221,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":180280748},{"date":"2022-05-13","current":-3.158221,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":180280748},{"date":"2022-05-20","current":-3.090448,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":176412063},{"date":"2022-05-27","current":-3.158221,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":180280748},{"date":"2022-06-03","current":-3.171776,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":181054486},{"date":"2022-06-10","current":-3.022675,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":172543377},{"date":"2022-06-17","current":-3.049785,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":174090852},{"date":"2022-06-24","current":-3.903724,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":222836290},{"date":"2022-07-01","current":-3.822397,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":218193867},{"date":"2022-07-08","current":-4.622118,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":263844357},{"date":"2022-07-15","current":-5.015201,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":286282734},{"date":"2022-07-22","current":-4.581454,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":261523146},{"date":"2022-07-29","current":-3.903546,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":230832318},{"date":"2022-08-05","current":-4.448227,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":263041479},{"date":"2022-08-12","current":-4.876191,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":288348677},{"date":"2022-08-19","current":-4.616819,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":273010981},{"date":"2022-08-26","current":-4.318541,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":255372631},{"date":"2022-09-02","current":-4.111044,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":243102475},{"date":"2022-09-09","current":-4.085107,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":241568705},{"date":"2022-09-16","current":-4.188856,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":247703783},{"date":"2022-09-23","current":-3.449646,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":203991351},{"date":"2022-09-30","current":-3.527457,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":208592660},{"date":"2022-10-07","current":-3.721986,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":220095931},{"date":"2022-10-14","current":-4.24073,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":250771323},{"date":"2022-10-21","current":-5.317123,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":314422759},{"date":"2022-10-28","current":-5.173587,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":319024068},{"date":"2022-11-04","current":-5.273079,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":325159146},{"date":"2022-11-11","current":-5.19846,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":320557838},{"date":"2022-11-18","current":-4.974603,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":306753912},{"date":"2022-11-25","current":-4.987039,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":307520796},{"date":"2022-12-02","current":-5.297952,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":326692916},{"date":"2022-12-09","current":-4.576635,"twenty":-25.386992,"median":-13.535653,"eighty":-7.244999,"marketCap":282213599},{"date":"2022-12-16","current":-4.999476,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":308287681},{"date":"2022-12-23","current":-10.508849,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":648017639},{"date":"2022-12-30","current":-11.690317,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":720871693},{"date":"2023-01-06","current":-10.496412,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":647250754},{"date":"2023-01-13","current":-11.130674,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":686361878},{"date":"2023-01-20","current":-10.794888,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":665655989},{"date":"2023-01-27","current":-10.658087,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":657220256},{"date":"2023-02-03","current":-11.317222,"twenty":-25.386992,"median":-13.524439,"eighty":-7.119431,"marketCap":697865149},{"date":"2023-02-10","current":-12.149879,"twenty":-25.386992,"median":-13.434725,"eighty":-7.119431,"marketCap":836725704},{"date":"2023-02-17","current":-12.85587,"twenty":-25.386992,"median":-13.334708,"eighty":-7.119431,"marketCap":885345192},{"date":"2023-02-24","current":-12.525648,"twenty":-25.386992,"median":-13.255296,"eighty":-7.119431,"marketCap":862603819},{"date":"2023-03-03","current":-13.470765,"twenty":-25.386992,"median":-13.213514,"eighty":-7.119431,"marketCap":927691198},{"date":"2023-03-10","current":-11.785496,"twenty":-25.386992,"median":-13.158792,"eighty":-7.119431,"marketCap":811631775},{"date":"2023-03-17","current":-13.470765,"twenty":-25.386992,"median":-13.120724,"eighty":-7.119431,"marketCap":927691198},{"date":"2023-03-24","current":-10.077453,"twenty":-25.386992,"median":-13.112183,"eighty":-7.119431,"marketCap":694003981},{"date":"2023-03-31","current":-23.127881,"twenty":-25.374695,"median":-13.132194,"eighty":-7.122351,"marketCap":1592747807},{"date":"2023-04-06","current":-27.368372,"twenty":-25.498525,"median":-13.200762,"eighty":-7.122351,"marketCap":1884777689},{"date":"2023-04-14","current":-31.225434,"twenty":-25.600181,"median":-13.255296,"eighty":-7.119431,"marketCap":2150401995},{"date":"2023-04-21","current":-29.188583,"twenty":-25.700564,"median":-13.388585,"eighty":-7.119431,"marketCap":2010130121},{"date":"2023-04-28","current":-26.649427,"twenty":-25.824845,"median":-13.470765,"eighty":-7.119431,"marketCap":1926620316},{"date":"2023-05-05","current":-29.92626,"twenty":-25.971096,"median":-13.535653,"eighty":-7.119431,"marketCap":2163518996},{"date":"2023-05-12","current":-31.6387,"twenty":-26.182902,"median":-13.578304,"eighty":-7.119431,"marketCap":2287319806},{"date":"2023-05-19","current":-32.01157,"twenty":-26.537926,"median":-13.59857,"eighty":-7.119431,"marketCap":2314276434},{"date":"2023-05-26","current":-28.862891,"twenty":-26.646108,"median":-13.636582,"eighty":-7.119431,"marketCap":2086642686},{"date":"2023-06-02","current":-30.34056,"twenty":-26.780985,"median":-13.659011,"eighty":-7.119431,"marketCap":2193470805},{"date":"2023-06-09","current":-34.234979,"twenty":-26.930727,"median":-13.659011,"eighty":-7.119431,"marketCap":2475017808},{"date":"2023-06-16","current":-31.01725,"twenty":-26.930727,"median":-13.659011,"eighty":-7.119431,"marketCap":2242392092},{"date":"2023-06-23","current":-30.10579,"twenty":-26.891574,"median":-13.647797,"eighty":-7.11651,"marketCap":2176498113},{"date":"2023-06-30","current":-21.571213,"twenty":-26.72914,"median":-13.636582,"eighty":-7.11359,"marketCap":1559490850},{"date":"2023-07-07","current":-22.082183,"twenty":-26.566581,"median":-13.636582,"eighty":-7.11359,"marketCap":1596431414},{"date":"2023-07-14","current":-21.736933,"twenty":-26.246081,"median":-13.636582,"eighty":-7.11359,"marketCap":1571471573},{"date":"2023-07-21","current":-20.991193,"twenty":-26.032581,"median":-13.636582,"eighty":-7.11359,"marketCap":1517558317},{"date":"2023-07-28","current":-18.510356,"twenty":-25.900267,"median":-13.636582,"eighty":-7.11359,"marketCap":1371395231},{"date":"2023-08-04","current":-18.226827,"twenty":-25.725158,"median":-13.636582,"eighty":-7.11359,"marketCap":1350389178},{"date":"2023-08-11","current":-20.090014,"twenty":-25.632931,"median":-13.636582,"eighty":-7.11359,"marketCap":1488428960},{"date":"2023-08-18","current":-19.090914,"twenty":-25.535318,"median":-13.636582,"eighty":-7.11359,"marketCap":1414407627},{"date":"2023-08-25","current":-18.348339,"twenty":-25.35625,"median":-13.636582,"eighty":-7.11359,"marketCap":1359391772},{"date":"2023-09-01","current":-18.645369,"twenty":-25.270172,"median":-13.636582,"eighty":-7.11359,"marketCap":1381398114},{"date":"2023-09-08","current":-19.725477,"twenty":-25.104163,"median":-13.636582,"eighty":-7.11359,"marketCap":1461421177},{"date":"2023-09-15","current":-20.25203,"twenty":-24.980609,"median":-13.636582,"eighty":-7.11359,"marketCap":1500432420},{"date":"2023-09-22","current":-17.970302,"twenty":-24.737721,"median":-13.636582,"eighty":-7.11359,"marketCap":1331383700},{"date":"2023-09-29","current":-15.148519,"twenty":-24.618435,"median":-13.636582,"eighty":-7.11359,"marketCap":1122323450},{"date":"2023-10-06","current":-15.067511,"twenty":-24.500824,"median":-13.636582,"eighty":-7.11359,"marketCap":1116321720},{"date":"2023-10-13","current":-14.973001,"twenty":-24.433267,"median":-13.636582,"eighty":-7.11359,"marketCap":1109319702},{"date":"2023-10-20","current":-13.636367,"twenty":-24.347195,"median":-13.636367,"eighty":-7.11359,"marketCap":1010291162},{"date":"2023-10-27","current":-11.957845,"twenty":-24.235304,"median":-13.588437,"eighty":-7.10483,"marketCap":966779830},{"date":"2023-11-03","current":-12.100127,"twenty":-24.100234,"median":-13.537772,"eighty":-7.10483,"marketCap":978283160},{"date":"2023-11-10","current":-11.753702,"twenty":-23.899065,"median":-13.487141,"eighty":-7.10483,"marketCap":950275053},{"date":"2023-11-17","current":-13.028051,"twenty":-23.701223,"median":-13.463736,"eighty":-7.10483,"marketCap":1053304875},{"date":"2023-11-24","current":-15.193206,"twenty":-23.64083,"median":-13.463736,"eighty":-7.10483,"marketCap":1228355542},{"date":"2023-12-01","current":-15.118972,"twenty":-23.382093,"median":-13.463736,"eighty":-7.10483,"marketCap":1222353805},{"date":"2023-12-08","current":-22.319661,"twenty":-23.156555,"median":-13.470765,"eighty":-7.10775,"marketCap":1804522312},{"date":"2023-12-15","current":-23.779595,"twenty":-22.865343,"median":-13.470765,"eighty":-7.10775,"marketCap":1922556476},{"date":"2023-12-22","current":-22.282545,"twenty":-22.81441,"median":-13.470765,"eighty":-7.10775,"marketCap":1801521443},{"date":"2023-12-29","current":-23.841457,"twenty":-22.774551,"median":-13.463736,"eighty":-7.10483,"marketCap":1927557924},{"date":"2024-01-05","current":-22.987767,"twenty":-22.665451,"median":-13.456707,"eighty":-7.101909,"marketCap":1858537946},{"date":"2024-01-12","current":-26.018985,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":2103608881},{"date":"2024-01-19","current":-25.907634,"twenty":-22.612622,"median":-13.445716,"eighty":-7.098989,"marketCap":2094606275},{"date":"2024-01-26","current":-26.612856,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":2151622779},{"date":"2024-02-02","current":-29.631701,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":2395693424},{"date":"2024-02-09","current":-33.798336,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":2903108113},{"date":"2024-02-16","current":-37.261233,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":3200553597},{"date":"2024-02-23","current":-41.718542,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":3583414168},{"date":"2024-03-01","current":-97.224678,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":8351113716},{"date":"2024-03-08","current":-94.212301,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":8092365608},{"date":"2024-03-15","current":-82.817705,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":7113626794},{"date":"2024-03-22","current":-89.870896,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":7719460652},{"date":"2024-03-28","current":-106.103421,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":9113753375},{"date":"2024-04-05","current":-93.804897,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":8057371594},{"date":"2024-04-12","current":-90.938346,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":7811149234},{"date":"2024-04-19","current":-82.982684,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":7127797671},{"date":"2024-04-26","current":-81.018661,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":7593068940},{"date":"2024-05-03","current":-89.136999,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":8353919589},{"date":"2024-05-10","current":-94.360974,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":8843510442},{"date":"2024-05-17","current":-81.253975,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":7615122582},{"date":"2024-05-24","current":-72.441461,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":6789213689},{"date":"2024-05-31","current":-73.253294,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":6865298754},{"date":"2024-06-07","current":-65.876196,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":6173917077},{"date":"2024-06-14","current":-61.20521,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":5736152284},{"date":"2024-06-21","current":-62.052341,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":5815545395},{"date":"2024-06-28","current":-62.370015,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":5845317812},{"date":"2024-07-05","current":-60.322782,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":5653451126},{"date":"2024-07-12","current":-67.276315,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":6305136247},{"date":"2024-07-19","current":-59.887451,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":5612651889},{"date":"2024-07-26","current":-75.562905,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":7310333276},{"date":"2024-08-02","current":-60.754958,"twenty":-22.665451,"median":-13.456707,"eighty":-7.101909,"marketCap":5877738410},{"date":"2024-08-09","current":-65.461893,"twenty":-22.849095,"median":-13.456707,"eighty":-7.101909,"marketCap":6333110792},{"date":"2024-08-16","current":-64.946535,"twenty":-23.213902,"median":-13.456707,"eighty":-7.101909,"marketCap":6283252502},{"date":"2024-08-23","current":-74.016832,"twenty":-23.457915,"median":-13.456707,"eighty":-7.101909,"marketCap":7160758406},{"date":"2024-08-30","current":-73.43276,"twenty":-23.676304,"median":-13.456707,"eighty":-7.101909,"marketCap":7104252344},{"date":"2024-09-06","current":-61.991817,"twenty":-23.75485,"median":-13.456707,"eighty":-7.101909,"marketCap":5997398306},{"date":"2024-09-13","current":-76.421835,"twenty":-23.999377,"median":-13.456707,"eighty":-7.101909,"marketCap":7393430426},{"date":"2024-09-20","current":-80.705031,"twenty":-24.258515,"median":-13.456707,"eighty":-7.101909,"marketCap":7807808214},{"date":"2024-09-27","current":-70.581113,"twenty":-24.3935,"median":-13.456707,"eighty":-7.101909,"marketCap":6828369806},{"date":"2024-10-04","current":-74.394761,"twenty":-24.681628,"median":-13.456707,"eighty":-7.101909,"marketCap":7197321152},{"date":"2024-10-11","current":-75.402572,"twenty":-25.521724,"median":-13.456707,"eighty":-7.101909,"marketCap":7294821808},{"date":"2024-10-18","current":-75.356762,"twenty":-26.385205,"median":-13.456707,"eighty":-7.101909,"marketCap":7290389960},{"date":"2024-10-25","current":-87.69837,"twenty":-26.594869,"median":-13.456707,"eighty":-7.101909,"marketCap":8695381043},{"date":"2024-11-01","current":-81.910255,"twenty":-26.759549,"median":-13.456707,"eighty":-7.101909,"marketCap":8121483665},{"date":"2024-11-08","current":-76.965069,"twenty":-27.991529,"median":-13.456707,"eighty":-7.101909,"marketCap":7631163576},{"date":"2024-11-15","current":-55.72325,"twenty":-28.465539,"median":-13.456707,"eighty":-7.101909,"marketCap":5525015918},{"date":"2024-11-22","current":-59.106206,"twenty":-28.945751,"median":-13.456707,"eighty":-7.101909,"marketCap":5860439434},{"date":"2024-11-29","current":-59.499573,"twenty":-29.157738,"median":-13.456707,"eighty":-7.101909,"marketCap":5899442168},{"date":"2024-12-06","current":-57.094415,"twenty":-29.606349,"median":-13.456707,"eighty":-7.101909,"marketCap":5660968307},{"date":"2024-12-13","current":-52.85729,"twenty":-29.813233,"median":-13.456707,"eighty":-7.101909,"marketCap":5240853139},{"date":"2024-12-20","current":-47.48502,"twenty":-30.230587,"median":-13.456707,"eighty":-7.101909,"marketCap":4708187224},{"date":"2024-12-27","current":-46.259963,"twenty":-30.358565,"median":-13.456707,"eighty":-7.101909,"marketCap":4586721565},{"date":"2025-01-03","current":-48.20432,"twenty":-30.49363,"median":-13.456707,"eighty":-7.101909,"marketCap":4779506509},{"date":"2025-01-10","current":-44.180737,"twenty":-31.014488,"median":-13.445716,"eighty":-7.098989,"marketCap":4380564255},{"date":"2025-01-17","current":-36.695524,"twenty":-31.547554,"median":-13.445716,"eighty":-7.098989,"marketCap":3638397937},{"date":"2025-01-24","current":-38.77475,"twenty":-31.83204,"median":-13.445716,"eighty":-7.098989,"marketCap":3844555248},{"date":"2025-01-31","current":-36.807915,"twenty":-33.456095,"median":-13.445716,"eighty":-7.098989,"marketCap":3649541576},{"date":"2025-02-07","current":-33.036874,"twenty":-33.696389,"median":-13.445716,"eighty":-7.098989,"marketCap":3632833778},{"date":"2025-02-14","current":-30.92641,"twenty":-33.696389,"median":-13.445716,"eighty":-7.098989,"marketCap":3400760859},{"date":"2025-02-21","current":-34.568989,"twenty":-33.780709,"median":-13.445716,"eighty":-7.098989,"marketCap":3801309792},{"date":"2025-02-28","current":-29.46986,"twenty":-33.780709,"median":-13.445716,"eighty":-7.098989,"marketCap":3240594245},{"date":"2025-03-07","current":-29.704639,"twenty":-33.798336,"median":-13.434725,"eighty":-7.096069,"marketCap":3266411241},{"date":"2025-03-14","current":-31.531832,"twenty":-33.798336,"median":-13.470765,"eighty":-7.096069,"marketCap":3467334820},{"date":"2025-03-21","current":-29.551523,"twenty":-33.798336,"median":-13.524439,"eighty":-7.096069,"marketCap":3249574070},{"date":"2025-03-28","current":-26.182955,"twenty":-33.798336,"median":-13.541858,"eighty":-7.096069,"marketCap":2879156300},{"date":"2025-04-04","current":-23.089998,"twenty":-33.798336,"median":-13.59857,"eighty":-7.096069,"marketCap":2539045439},{"date":"2025-04-11","current":-22.689961,"twenty":-33.780709,"median":-13.641625,"eighty":-7.098989,"marketCap":2495056224},{"date":"2025-04-17","current":-24.44634,"twenty":-33.780709,"median":-13.641625,"eighty":-7.098989,"marketCap":2688192890},{"date":"2025-04-25","current":-21.886331,"twenty":-33.798336,"median":-13.636582,"eighty":-7.096069,"marketCap":2806615529},{"date":"2025-05-02","current":-25.713592,"twenty":-33.798336,"median":-13.646667,"eighty":-7.096069,"marketCap":3297408241},{"date":"2025-05-09","current":-24.128388,"twenty":-33.798336,"median":-13.646667,"eighty":-7.096069,"marketCap":3094127964},{"date":"2025-05-16","current":-24.899095,"twenty":-33.798336,"median":-13.646667,"eighty":-7.096069,"marketCap":3192960364},{"date":"2025-05-23","current":-24.286033,"twenty":-33.798336,"median":-13.646667,"eighty":-7.096069,"marketCap":3114343682},{"date":"2025-05-30","current":-24.662628,"twenty":-33.798336,"median":-13.646667,"eighty":-7.096069,"marketCap":3162636787},{"date":"2025-06-06","current":-23.681728,"twenty":-33.798336,"median":-13.646667,"eighty":-7.096069,"marketCap":3036850096},{"date":"2025-06-13","current":-25.030466,"twenty":-33.798336,"median":-13.646667,"eighty":-7.096069,"marketCap":3209806796},{"date":"2025-06-20","current":-23.016117,"twenty":-33.836797,"median":-13.641625,"eighty":-7.096069,"marketCap":2951494842},{"date":"2025-06-27","current":-24.671386,"twenty":-33.836797,"median":-13.641625,"eighty":-7.096069,"marketCap":3163759882},{"date":"2025-07-03","current":-24.688902,"twenty":-33.836797,"median":-13.641625,"eighty":-7.096069,"marketCap":3166006073},{"date":"2025-07-11","current":-27.403893,"twenty":-33.836797,"median":-13.641625,"eighty":-7.096069,"marketCap":3514165663},{"date":"2025-07-18","current":-28.08702,"twenty":-33.836797,"median":-13.641625,"eighty":-7.096069,"marketCap":3601767108},{"date":"2025-07-25","current":-21.95845,"twenty":-33.836797,"median":-13.641625,"eighty":-7.096069,"marketCap":3766906193},{"date":"2025-08-01","current":-21.348857,"twenty":-33.836797,"median":-13.641625,"eighty":-7.096069,"marketCap":3662332379},{"date":"2025-08-08","current":-23.308731,"twenty":-33.836797,"median":-13.641625,"eighty":-7.096069,"marketCap":3998542813},{"date":"2025-08-15","current":-26.376359,"twenty":-33.836797,"median":-13.641625,"eighty":-7.096069,"marketCap":4524785230},{"date":"2025-08-22","current":-16.819517,"twenty":-33.836797,"median":-13.641625,"eighty":-7.096069,"marketCap":2885337699},{"date":"2025-08-29","current":-18.078031,"twenty":-33.836797,"median":-13.641625,"eighty":-7.096069,"marketCap":3101232024},{"date":"2025-09-05","current":-17.389781,"twenty":-33.875258,"median":-13.636582,"eighty":-7.096069,"marketCap":2983164815},{"date":"2025-09-12","current":-16.871955,"twenty":-33.836797,"median":-13.726296,"eighty":-7.096069,"marketCap":2894333296},{"date":"2025-09-19","current":-17.068598,"twenty":-33.836797,"median":-13.743498,"eighty":-7.096069,"marketCap":2928066784},{"date":"2025-09-26","current":-16.445896,"twenty":-33.836797,"median":-13.831631,"eighty":-7.096069,"marketCap":2821244071},{"date":"2025-10-03","current":-18.274674,"twenty":-33.836797,"median":-14.088292,"eighty":-7.096069,"marketCap":3134965512},{"date":"2025-10-10","current":-22.928554,"twenty":-33.836797,"median":-14.513907,"eighty":-7.096069,"marketCap":3933324735},{"date":"2025-10-17","current":-22.764685,"twenty":-33.836797,"median":-14.656212,"eighty":-7.096069,"marketCap":3905213495},{"date":"2025-10-24","current":-16.066964,"twenty":-33.836797,"median":-14.830659,"eighty":-7.096069,"marketCap":3814200917},{"date":"2025-10-31","current":-18.080072,"twenty":-33.836797,"median":-15.126957,"eighty":-7.096069,"marketCap":4292100501},{"date":"2025-11-07","current":-17.746297,"twenty":-33.836797,"median":-15.229993,"eighty":-7.096069,"marketCap":4212864540},{"date":"2025-11-14","current":-18.570046,"twenty":-33.836797,"median":-15.525615,"eighty":-7.096069,"marketCap":4408417416},{"date":"2025-11-21","current":-16.317832,"twenty":-33.836797,"median":-15.812115,"eighty":-7.096069,"marketCap":3873755508},{"date":"2025-11-28","current":-17.527266,"twenty":-33.836797,"median":-16.098375,"eighty":-7.096069,"marketCap":4160867822},{"date":"2025-12-05","current":-18.365299,"twenty":-33.836797,"median":-16.315452,"eighty":-7.096069,"marketCap":4359811788},{"date":"2025-12-12","current":-17.717728,"twenty":-33.836797,"median":-16.470202,"eighty":-7.096069,"marketCap":4206082360},{"date":"2025-12-19","current":-16.165463,"twenty":-33.836797,"median":-16.554627,"eighty":-7.096069,"marketCap":3837583878},{"date":"2025-12-26","current":-17.78439,"twenty":-33.836797,"median":-16.728713,"eighty":-7.096069,"marketCap":4221907448},{"date":"2026-01-02","current":-16.751133,"twenty":-33.836797,"median":-16.818656,"eighty":-7.096069,"marketCap":3976618581},{"date":"2026-01-09","current":-15.070306,"twenty":-33.836797,"median":-16.829349,"eighty":-7.096069,"marketCap":3577600287},{"date":"2026-01-16","current":-15.179822,"twenty":-33.836797,"median":-16.829349,"eighty":-7.096069,"marketCap":3603598646},{"date":"2026-01-23","current":-16.232125,"twenty":-33.836797,"median":-16.829349,"eighty":-7.096069,"marketCap":3853408966},{"date":"2026-01-30","current":-14.398928,"twenty":-33.836797,"median":-16.829349,"eighty":-7.096069,"marketCap":3418219042},{"date":"2026-02-06","current":-12.518115,"twenty":-33.836797,"median":-16.78916,"eighty":-7.096069,"marketCap":2971725483},{"date":"2026-02-13","current":-9.796631,"twenty":-33.836797,"median":-16.665916,"eighty":-7.096069,"marketCap":3523250454},{"date":"2026-02-20","current":-9.992628,"twenty":-33.836797,"median":-16.606487,"eighty":-7.096069,"marketCap":3593738574},{"date":"2026-02-27","current":-10.59347,"twenty":-33.836797,"median":-16.606487,"eighty":-7.096069,"marketCap":3809825106},{"date":"2026-03-06","current":-10.124363,"twenty":-33.836797,"median":-16.606487,"eighty":-7.096069,"marketCap":3641115835},{"date":"2026-03-13","current":-11.396736,"twenty":-33.836797,"median":-16.606487,"eighty":-7.096069,"marketCap":4098710843},{"date":"2026-03-20","current":-10.898711,"twenty":-33.836797,"median":-16.606487,"eighty":-7.096069,"marketCap":3919601686},{"date":"2026-03-27","current":-11.004743,"twenty":-33.836797,"median":-16.606487,"eighty":-7.096069,"marketCap":3957734603}],"updateTime":1774699877088},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VKTX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608980980","title":"Obesity Drugmakers and Developers Fall After Rival Novo Nordisk Warns of Steep 2026 Sales Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2608980980","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608980980?lang=en_us&edition=fundamental","pubTime":"2026-02-04 01:33","pubTimestamp":1770140018,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"bcb73b9a2718796b6bdfcc143da1014d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nFWN3YZ177:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4599","LU2089984988.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4566","LU2112291526.USD","LU0109394709.USD","LU1571399168.USD","LU0058720904.USD","LU1061106388.HKD","LU0320765992.SGD","BK4533","IE0009355771.USD","BK4007","LU2242652126.USD","BK4139","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU1983299246.USD","LU0868494617.USD","LU0889565916.HKD","IE00BJT1NW94.SGD","LU0122379950.USD","BK4534","GPCR","LU2468319806.SGD","VKTX","LU1023059063.AUD","BK4588","LU2242646821.SGD","BK4581","BK4585","AMGN","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2608809553","title":"Structure Therapeutics Down 5.3%, Viking Therapeutics Down 3.3%, Amgen Down 1.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608809553","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608809553?lang=en_us&edition=fundamental","pubTime":"2026-02-04 01:33","pubTimestamp":1770140018,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nFWN3YZ177:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739699.SGD","LU2089984988.USD","LU0122379950.USD","IE0002141913.USD","BK4007","LU2242646821.SGD","BK4566","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","BK4588","IE00BJT1NW94.SGD","LU1023059063.AUD","LU2112291526.USD","LU0320765992.SGD","LU0058720904.USD","IE00B2B36J28.USD","LU1983299246.USD","SG9999001440.SGD","LU1571399168.USD","IE0009355771.USD","BK4585","BK4581","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","GPCR","LU1057294990.SGD","BK4599","BK4139","BK4533","VKTX","LU2242652126.USD","LU1061106388.HKD","LU0868494617.USD","AMGN","LU0889565916.HKD","BK4534"],"gpt_icon":0},{"id":"2608137818","title":"Viking Therapeutics stellt neue klinische Fortschritte bei Medikamenten gegen Adipositas und Stoffwechselkrankheiten vor","url":"https://stock-news.laohu8.com/highlight/detail?id=2608137818","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608137818?lang=en_us&edition=fundamental","pubTime":"2026-02-03 05:37","pubTimestamp":1770068231,"startTime":"0","endTime":"0","summary":"Viking Therapeutics Inc. hat eine Prsentation verffentlicht, in der aktuelle Fortschritte in der Entwicklung neuartiger Therapeutika für metabolische und endokrine Erkrankungen vorgestellt werden. Zu den Schwerpunkten zhlen das Phase-3-Programm mit dem dualen GLP-1/GIP-Agonisten VK2735 zur Behandlung von Adipositas, positive Phase-2b-Daten zum selektiven Schilddrüsenhormonrezeptor-β-Agonisten VK2809 bei MASH sowie erfolgreiche Phase-1b-Daten für VK0214 bei X-ALD. Darüber hinaus wurde für einen Amylin-Agonisten ein IND-Antrag für das erste Quartal 2026 angekündigt. Die vollstndige Prsentation knnen Sie über den untenstehenden Link abrufen.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viking Therapeutics Inc. published the original con","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDL6XhSgz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4588","VKTX","BK4139","BK4585"],"gpt_icon":0},{"id":"2607467117","title":"Analysts Are Bullish on Top Healthcare Stocks: GH Research (GHRS), Viking Therapeutics (VKTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2607467117","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607467117?lang=en_us&edition=fundamental","pubTime":"2026-01-29 01:20","pubTimestamp":1769620821,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on GH Research (GHRS – Research Report), Viking Therape...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-gh-research-ghrs-viking-therapeutics-vktx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-gh-research-ghrs-viking-therapeutics-vktx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4112","BK4007","LU0029874061.USD","BK4581","XBI","BK4588","GHRS","BK4137","BK4585","BK4535","BK4551","LABU","BK4139","BK4539","BK4196","BK4599","VKTX"],"gpt_icon":0},{"id":"2606207202","title":"Viking Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Chief Commercial Officer Neil William Aubuchon","url":"https://stock-news.laohu8.com/highlight/detail?id=2606207202","media":"Reuters","labels":["executive","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606207202?lang=en_us&edition=fundamental","pubTime":"2026-01-27 08:56","pubTimestamp":1769475391,"startTime":"0","endTime":"0","summary":"Viking Therapeutics Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Neil William Aubuchon as the beneficial owner, serving as Chief Commercial Officer of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viking Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nNDL89RGVd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Viking Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Chief Commercial Officer Neil William Aubuchon","news_tag":"executive,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4599","BK4585","VKTX","BK4139"],"gpt_icon":0},{"id":"2603642839","title":"Viking Therapeutics Showcases Advancements in Obesity and Metabolic Disease Pipeline in New Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2603642839","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603642839?lang=en_us&edition=fundamental","pubTime":"2026-01-15 05:16","pubTimestamp":1768425368,"startTime":"0","endTime":"0","summary":"Viking Therapeutics Inc. has released a corporate presentation detailing progress across its pipeline of metabolic and endocrine disease therapeutics. Key highlights include the ongoing Phase 3 VANQUISH program evaluating VK2735, a dual GLP-1/GIP agonist for obesity, and the successful completion of the Phase 2a VENTURE Oral study for the tablet formulation of VK2735, which achieved its primary endpoint. The company also reported positive Phase 2b data for VK2809 in MASH and successful Phase 1b results for VK0214 in X-ALD. An investigational new drug application for an amylin agonist targeting obesity is planned for the first quarter of 2026. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDL5drCtY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VKTX","BK4588","BK4599","BK4585","BK4139"],"gpt_icon":0},{"id":"2603816527","title":"Appetite for weight-loss deals broader than visible, Viking CEO says","url":"https://stock-news.laohu8.com/highlight/detail?id=2603816527","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603816527?lang=en_us&edition=fundamental","pubTime":"2026-01-13 08:15","pubTimestamp":1768263326,"startTime":"0","endTime":"0","summary":"Appetite for weight-loss deals broader than visible, Viking CEO saysBy Puyaan SinghJan 12 (Reuters) - Weight-loss drug developer Viking Therapeutics VKTX.O CEO said on Monday that strategic interest i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nL4N3YD1YL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0496365809.HKD","LU2236285917.USD","LU2417539215.USD","IE00BKDWB100.SGD","LU0345770308.USD","LU0787776722.HKD","LU1066053197.SGD","SG9999001176.USD","LU1267930490.SGD","LU0058720904.USD","LU1883839398.USD","BK4588","LU1244550221.USD","IE00B1BXHZ80.USD","LU1032466523.USD","IE00BBT3K403.USD","IE00BN8TJ469.HKD","LU0942090050.USD","BK4007","LU0640476718.USD","LU0868494617.USD","LU0306807586.USD","BK4581","LU0211331839.USD","LU0985481810.HKD","LU0225771236.USD","LU0820562030.AUD","LU1261432733.SGD","LU0683600562.USD","LU2462157665.USD","LU0345770993.USD","SGXZ57979304.SGD","LU0251132253.USD","LU0310799852.SGD","LU2023250843.SGD","SG9999003800.SGD","LU0320765489.SGD","LU0048584097.USD","IE00BKVL7J92.USD","LU0006306889.USD","LU1496350502.SGD","LU2237443549.SGD","LU1119994496.HKD","LU2237443622.USD","LU0203345920.USD","LU2054465674.USD","IE00B1XK9C88.USD","LU0976567544.SGD","LU1057294990.SGD","LU1363072403.SGD","LU2381873111.SGD","BK4599","BK4516","IE00B19Z3B42.SGD","LU2505996681.GBP","LU0106831901.USD","LU0170899867.USD","IE00BWXC8680.SGD","SG9999013999.USD","LU0820561818.USD","IE0034235188.USD","LU0211326755.USD","SG9999002224.SGD","LU0070302665.USD","IE0034235303.USD","LU0820561909.HKD","LU2023250504.SGD","LU1116320901.HKD","LU0306806265.USD","LU2756315664.SGD","LU0238689110.USD","LU1668664300.SGD","VKTX","IE00BZ1G4Q59.USD","LU0106261372.USD","LU1496350171.SGD","LU0289739699.SGD","LU1366192091.USD","LU1720051017.SGD","LU1023059063.AUD","LU2430703178.SGD","LU0203347892.USD","LU0321505439.SGD","LU0456855351.SGD","BK4568","LU0267386448.USD","LU1629891620.HKD","LU0211328371.USD","LU2264538146.SGD","IE00B19Z3581.USD","BK4592","LU0943347566.SGD","LU2456880835.USD","LU1066051498.USD","LU2756315318.SGD","LU0320765646.SGD","IE00BDCRKT87.USD","LU1548497426.USD","LU2592432038.USD","LU0971096721.USD","LU1084165304.USD","LU0321505868.SGD","SG9999001176.SGD","IE00B775SV38.USD","IE00BLSP4239.USD","LU2237443465.HKD","LU0149725797.USD","IE00BHPRN162.USD","IE00BJTD4V19.USD","BK4534","LU1974910355.USD","LU2237443382.USD","LU2430703251.USD","LU2242649171.HKD","LU1670627923.USD","LU2505996509.AUD","BK4207","LU0211326839.USD","LU2552382132.HKD","LU0689472784.USD","BK4550","LU2552382215.SGD","LU1064131342.USD","IE000M9KFDE8.USD","LU1551013342.USD","LU1670628061.USD","LU0122379950.USD","LU0265550359.USD","LU0345769631.USD","LU0868494708.USD","LU0256863811.USD","LU0265550946.USD","LU0345769128.USD","LU2211815571.USD","LU0234572021.USD","IE0034235295.USD","LU0215105999.USD","IE00B3S45H60.SGD","LU1914381329.SGD","LU2237443895.HKD","LU2746668461.USD","IE00BYXW3230.USD","LU1244550577.SGD","LU2746668974.SGD","IE0002270589.USD","LU1917777945.USD","LU2357305700.SGD","LU2552382058.USD","LU2106854487.HKD","LU0417517546.SGD","LU0208291251.USD","LU0882574139.USD","BK4504","BK4139","IE00BDRTCR15.USD","IE00BJTD4N35.SGD","LU1116320737.USD","IE00BFXG1179.USD","LU0225284248.USD","LU2023250330.USD","BK4533","SG9999011175.SGD","LU1145028129.USD","LU1244550494.USD","LU2237443978.SGD","BK4585","LU1162221912.USD","LU1894683348.USD","LU0323591593.USD","LU1720051108.HKD","IE00BLSP4452.SGD","LU1551013425.SGD","LU1280957306.USD","LU1988902786.USD","LU2213496289.HKD","LU0964807845.USD","LU1894683264.USD","BK4566","IE00BJLML261.HKD","LU2430703095.HKD","LU0211327993.USD","SG9999002232.USD"],"gpt_icon":0},{"id":"2602851415","title":"Viking Therapeutics Reports Phase 2 Trial Shows VK2735 Achieves Up to 14.7% Weight Loss in Obesity Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2602851415","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602851415?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:02","pubTimestamp":1768219379,"startTime":"0","endTime":"0","summary":"Viking Therapeutics Inc. has announced the publication of results from its Phase 2 VENTURE clinical trial evaluating VK2735, a dual GLP-1/GIP receptor agonist, in the journal Obesity. The study reported weight loss of up to 14.7% from baseline after 13 weeks of treatment in patients with obesity, with no plateau observed. VK2735 was generally well-tolerated, with most adverse events categorized as mild or moderate. The results have already been presented and published. VK2735 is currently being evaluated in two Phase 3 studies, VANQUISH-1 and VANQUISH-2, which are assessing the efficacy and safety of weekly subcutaneous dosing in adults with obesity or overweight, with or without type 2 diabetes. Enrollment for VANQUISH-1 has been completed, while VANQUISH-2 is expected to complete enrollment in the first quarter of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL5TgZPP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4588","VKTX","BK4139","BK4585"],"gpt_icon":0},{"id":"2602514527","title":"Viking Therapeutics Announces Publication of Results From Phase 2 Venture Trial of Dual Glp-1/Gip Receptor Agonist Vk2735 in the Journal Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2602514527","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602514527?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:00","pubTimestamp":1768219201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA4FJFXR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4588","BK4139","BK4599","VKTX"],"gpt_icon":0},{"id":"2602713993","title":"Viking Therapeutics (VKTX) Receives a Buy from Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2602713993","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602713993?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:55","pubTimestamp":1767966957,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Naz Rahman reiterated a Buy rating on Viking Therapeutics yesterday and set a price target of $70.00. The company’s shares clos...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/viking-therapeutics-vktx-receives-a-buy-from-maxim-group-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/viking-therapeutics-vktx-receives-a-buy-from-maxim-group-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","VKTX","BK4588","BK4139","BK4585"],"gpt_icon":0},{"id":"2602373512","title":"Viking Therapeutics: Timely VK2735 Clinical Progress and Flexible Dosing Drive Favorable Risk‑Reward and Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2602373512","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602373512?lang=en_us&edition=fundamental","pubTime":"2026-01-09 20:15","pubTimestamp":1767960954,"startTime":"0","endTime":"0","summary":"Viking Therapeutics, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Edward Nash from Canaccord Genuity mainta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/viking-therapeutics-timely-vk2735-clinical-progress-and-flexible-dosing-drive-favorable-risk‑reward-and-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/viking-therapeutics-timely-vk2735-clinical-progress-and-flexible-dosing-drive-favorable-risk‑reward-and-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","VKTX"],"gpt_icon":0},{"id":"2602963163","title":"Positioning Viking Therapeutics’ VK2735 as a Differentiated, Best-in-Class Obesity Franchise with Compelling Monthly Maintenance Potential Supporting a Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2602963163","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602963163?lang=en_us&edition=fundamental","pubTime":"2026-01-08 23:46","pubTimestamp":1767887183,"startTime":"0","endTime":"0","summary":"William Blair analyst Andy Hsieh has maintained their bullish stance on VKTX stock, giving a Buy rating today. Andy Hsieh has given his Buy rating ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positioning-viking-therapeutics-vk2735-as-a-differentiated-best-in-class-obesity-franchise-with-compelling-monthly-maintenance-potential-supporting-a-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positioning-viking-therapeutics-vk2735-as-a-differentiated-best-in-class-obesity-franchise-with-compelling-monthly-maintenance-potential-supporting-a-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VKTX"],"gpt_icon":0},{"id":"2601366472","title":"Viking Therapeutics Completes Enrollment for VK2735 Obesity Maintenance Dosing Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2601366472","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601366472?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:01","pubTimestamp":1767873698,"startTime":"0","endTime":"0","summary":"Viking Therapeutics Inc. announced the completion of patient enrollment in its exploratory maintenance dosing clinical trial of VK2735 for obesity. VK2735 is a dual agonist of the GLP-1 and GIP receptors, being developed in both oral and subcutaneous formulations for the treatment of metabolic disorders such as obesity. The Phase 1 study is evaluating various maintenance dosing regimens—including subcutaneous and oral administration—following initial weight loss achieved with weekly VK2735 treatment. Approximately 180 adults with obesity have been enrolled. Results from this study are expected to be reported later this year. In addition, Viking is conducting two Phase 3 trials  to assess the efficacy and safety of subcutaneous VK2735 in adults with obesity or overweight, with or without type 2 diabetes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL7lNvG2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","VKTX","BK4585","BK4599","BK4139"],"gpt_icon":0},{"id":"2601366195","title":"Viking Therapeutics Announces Completion of Enrollment in Maintenance Dosing Clinical Trial of Vk2735 in Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2601366195","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601366195?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:00","pubTimestamp":1767873603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA6C46SK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4599","BK4139","BK4588","VKTX"],"gpt_icon":0},{"id":"2601832336","title":"Will Viking Therapeutics’ New CCO Reframe VKTX’s Obesity Strategy Amid Intensifying GLP-1 Competition?","url":"https://stock-news.laohu8.com/highlight/detail?id=2601832336","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601832336?lang=en_us&edition=fundamental","pubTime":"2026-01-08 06:21","pubTimestamp":1767824478,"startTime":"0","endTime":"0","summary":"Viking Therapeutics has appointed industry veteran Neil Aubuchon as chief commercial officer and is preparing to highlight its late-stage obesity and liver disease programs at the upcoming J.P. Morgan Healthcare Conference, underscoring a shift toward commercialization in the cardiometabolic arena.\nAt the same time, intensifying competition and pricing moves in the obesity-drug market are pressuring expectations for Viking’s VK2735 program, making its new commercial leadership especially...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vktx/viking-therapeutics/news/will-viking-therapeutics-new-cco-reframe-vktxs-obesity-strat","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vktx/viking-therapeutics/news/will-viking-therapeutics-new-cco-reframe-vktxs-obesity-strat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GLP","BK4009","BK4590","LU0823414478.USD","BK4585","LU2294711713.HKD","LU2357125470.USD","VKTX","BK4588","LU2249611893.SGD","LU0823414551.USD","BK4599","CCO","LU2506951792.HKD","BK4144","BK4139"],"gpt_icon":0},{"id":"1146401006","title":"Weight-Loss Drugmakers' Stocks Jump. Structure Therapeutics up 5%; Eli Lilly Rises 4% to Record High; Amgen up 3%; Roche, Novo up Around 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146401006","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146401006?lang=en_us&edition=fundamental","pubTime":"2026-01-07 23:15","pubTimestamp":1767798955,"startTime":"0","endTime":"0","summary":"Weight-loss drugmakers' stocks jumped on Wednesday. Structure Therapeutics up 5%; Eli Lilly rose 4% to record high; Amgen up 3%; Roche, Novo up around 2%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Weight-Loss Drugmakers' Stocks Jump. Eli Lilly Rises 4% to Record High","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","RHHBY","GPCR","PFE","NVO","AMGN","VKTX"],"gpt_icon":0},{"id":"2601371870","title":"Press Release: Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2601371870","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601371870?lang=en_us&edition=fundamental","pubTime":"2026-01-07 20:00","pubTimestamp":1767787200,"startTime":"0","endTime":"0","summary":"Experienced Industry Leader with More than Two Decades of Global Commercialization and Marketing Expertise. SAN DIEGO, Jan. 7, 2026 /PRNewswire/ -- Viking Therapeutics, Inc.  , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the appointment of Neil Aubuchon as chief commercial officer. Mr. Aubuchon brings more than two decades of biopharmaceutical industry experience spanning leadership roles across global commercial and marketing functions including focus within the cardiometabolic space.Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel first-in-class or best-in-class therapies for the treatment of metabolic and endocrine disorders. Viking's research and development activities leverage its expertise in metabolism to develop innovative therapeutics designed to improve patients' lives. Viking's clinical programs include VK2735, a novel","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VKTX","BK4599","BK4139","AMN","BK4196","BK4585","BK4588"],"gpt_icon":0},{"id":"1123730705","title":"Weight-Loss Drugmakers' Stocks Jump. Arrowhead up over 17%; Structure Therapeutics up over 6%; Novo Nordisk up 5%; Viking, Pfizer, Eli Lilly up Around 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123730705","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123730705?lang=en_us&edition=fundamental","pubTime":"2026-01-06 23:05","pubTimestamp":1767711953,"startTime":"0","endTime":"0","summary":"Weight-loss drugmakers' stocks jumped. Arrowhead up over 17%; Structure Therapeutics up over 6%; Novo Nordisk up 5%; Viking, Pfizer, Eli Lilly up around 2%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"c7a5ad1f4c9cc897f075885965193731","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","PFE","VKTX","GPCR","RHHBY","AMGN","NVO"],"gpt_icon":1},{"id":"2594287008","title":"12 Days of Christmas? 12 Stocks That Are Gifts for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2594287008","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594287008?lang=en_us&edition=fundamental","pubTime":"2025-12-25 15:05","pubTimestamp":1766646309,"startTime":"0","endTime":"0","summary":"It's the holiday season, and what investors would probably like more than some spiked eggnog on Christmas morning are stocks that can be big winners in the new year.Amazon.com doesn't deliver those, though. Still, with the help of Wall Street, it's possible to develop a Santa-like list of nice and naughty names.Barron's  looked at the Russell 1000 group of stocks and used Wall Street ratings and price targets by sector to find presents for any type of investor.Some of the largest Magnificent Seven stocks jumped off the page. Nvidia, Amazon, and Microsoft shares are loved by the Street, with a Buy rating from more than 90% of the analysts covering them. The average Buy-rating ratio for stocks in the Russell 1000 is currently about 58%.Wall Street price targets can typically be read in one of two ways. It is the price an analyst expects a stock to trade at over the coming 12 months, or the price an investor can pay to earn an adequate return in the future.The average gain implied by targ","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"13d44e8d649e7e968597cd411f47871e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFSS7M15.SGD","LU2430703178.SGD","IE00BDRTCR15.USD","LU2290526834.HKD","IE00B775H168.HKD","BK4500","HK0000320223.HKD","LU0308772762.SGD","LU0979878070.USD","LU2357305700.SGD","BK4527","LU1914381329.SGD","LU0823434583.USD","LU1674673428.USD","LU1066051225.USD","LU2028103732.USD","LU2125909759.SGD","LU0345770308.USD","IE00BDCRKT87.USD","LU1323610961.USD","LU2746668974.SGD","LU0187121727.USD","LU2087621335.USD","NVDX","LU0029864427.USD","2NVD.UK","LU2592432038.USD","SG9999018857.SGD","LU1923622291.USD","NVDS","IE00BYXW3230.USD","BK4588","IE0009G5SDU7.USD","LU2089284900.SGD","LU0345769631.USD","IE00B19Z8W00.USD","IE00BWXC8680.SGD","LU2097344357.USD","LU0689626769.HKD","NVD2.UK","LU0472753341.HKD","LU2168564222.USD","IE0004086264.USD","LU0109391861.USD","LU0345768740.USD","LU2063271972.USD","LU2249611893.SGD","LU1923622614.USD","LU0251132253.USD","LU0157215616.USD","LU2357125470.USD","LU1988902786.USD","LU2023250504.SGD","IE00BJTD4N35.SGD","LU0256863811.USD","BK4549","LU2092627202.USD","LU0347712357.USD","LU1623119135.USD","LU2089985449.USD","LU1791710582.SGD","IE00BJTD4V19.USD","RARE","LU0444971666.USD","LU1429558221.USD","BK4592","IE000ITXATA3.USD","IE00BQXX3F31.USD","NVDU","LU1935043536.SGD","LU0323591593.USD","LU0158827948.USD","LU2430703095.HKD","IE00B4YYXB79.USD","IE00BJJMRX11.SGD","LU2360106780.USD","LU0320765059.SGD","LU1548497426.USD","LU2065171402.SGD","LU1116320737.USD","IE00B1BXHZ80.USD","LU2361045086.USD","LU1699723380.USD","LU0057025933.USD","LU0274383776.USD","LU2360107168.USD","IE00B3SWFQ91.USD","IE0009356076.USD","LU0345770993.USD","IE00B7KXQ091.USD","LU2168564149.EUR","LU1633808545.USD","LU1066053197.SGD","LU0070217475.USD","LU1244550577.SGD","IE0003U64NQ7.SGD","LU1934455194.USD","LU2602419157.SGD","LU0061475181.USD","LU0820561909.HKD","LU2023251221.USD","LU1435385759.SGD","LU2403377893.USD","LU2271345857.HKD","BK4551","TSLA","LU1917777945.USD","LU1861220033.SGD","LU1868837136.USD","LU0511384066.AUD","LU1935042488.USD","LU0868494617.USD","3NVD.UK","LU1037948897.HKD","LU0528227936.USD","LU2433249047.HKD","NVDD","LU1069344957.HKD","BK4529","LU1935042215.USD","LU0943347566.SGD","LU1280957306.USD","LU0965509283.SGD","LU2458330243.SGD","IE00B19Z8X17.USD","LU1868837300.USD","LU1267930730.SGD","LU0170899867.USD","LU1992135399.USD","LU0256863902.USD","LU0097036916.USD","LU2092937148.SGD","LU0861579265.USD","IE00B1XK9C88.USD","SG9999001424.SGD","LU1642822529.SGD","BK4598","LU2326559502.SGD","LU1821325948.USD","LU2456880835.USD","LU0823414478.USD","LU2272731600.USD","IE0004445239.USD","LU0079474960.USD","LU0265550359.USD","LU2264538146.SGD","LOAR","LU2491049909.HKD","LU2054465674.USD","LU2265009873.SGD","SG9999014914.USD","NVDY","LU0081259029.USD","SG9999004303.SGD","LU1242518857.USD","BK4550","SG9999015358.SGD","LU0210533765.USD","LU2417539215.USD","LU0289961442.SGD","LU2322448791.USD","BK4579","NVD3.UK","LU0082616367.USD","LU2125909916.SGD","LU0267386448.USD","LU1316542783.SGD","LU2471134523.USD","LU2506951792.HKD","LU2237957811.SGD","LU0234570918.USD","LU2125154935.USD","LU0823414551.USD","LU1145028129.USD","BK4605","LU1721428933.USD","BK4614","LU1934455277.USD","AUR","SG9999015978.USD","LU0640476718.USD","IE00B5949003.HKD","LU1868836591.USD","LU0128525929.USD","LU2211815571.USD","LU2750360997.AUD","SG9999015986.USD","NVDS.UK","QXO","LU0823421333.USD","LU0006306889.USD","LU0494093205.USD","LU2089283258.USD","BK4608","IE00BZ1G4Q59.USD","LU2750360641.GBP","LU0889565833.HKD","LU1261432733.SGD","LU2065169927.USD","LU0820562030.AUD","SGXZ81514606.USD","IE00BKVL7J92.USD","BK4141","LU0154236417.USD","LU1066051811.HKD","IE00BQXX3C00.GBP","LU0072462426.USD","BK4585","SG9999015945.SGD","LU2125154778.USD","IE00BD6J9T35.USD","LU0345768153.USD","LU0965508806.USD","LU2360032135.SGD","LU1814569148.SGD","LU2242650005.HKD","LU1242518931.SGD","LU2413666699.HKD","LU1839511570.USD","IE00BQXX3D17.EUR","LU2487616109.SGD","IE0034235295.USD","IE0004091025.USD","LU1923623000.USD","SG9999014575.USD","NVIW.SI","AMZN","LU1935042991.SGD","LU0476273544.USD","BK4534","LU2420271590.USD","LU1066051498.USD","LU2756315318.SGD","LU0882574139.USD","MSFT","SG9999014559.SGD","BK4554","NVDL","LU2250418816.HKD","LU0348723411.USD","LU0238689110.USD","LU2083900584.USD","HK0000306701.USD","NVDA","LU1868836757.USD","LU2491050071.SGD","LU1989764664.SGD","LU0466842654.USD","LU2125909247.SGD","LU0708995401.HKD","IE0034235188.USD","LU0683600562.USD","SG9999018865.SGD","IE00BKDWB100.SGD","LU1989772923.USD","LU1232071149.USD","LU0056508442.USD","LU1861215975.USD","IE00BK4W5M84.HKD","LU0175139822.USD","IE0005OL40V9.USD","LU0823434740.USD","IE0034235303.USD","GB00BDT5M118.USD","IE000KEQY171.SGD","LU2860962120.EUR","LU1951200564.SGD","LU2458330169.SGD","SG9999014880.SGD","LU2108987350.USD","VKTX","LU1804176565.USD","LU0225283273.USD","LU0719512351.SGD","LU2552382058.USD","LU0069063385.USD","LU0053666078.USD","LU1791710400.SGD","LU0642271901.SGD","LU0109392836.USD","LU0211328371.USD","LU0215105999.USD","LU0266013472.USD","LU2746668461.USD","LU2111349929.HKD","IE000YTNTUN2.SGD","LU0289739343.SGD","IE00BKPKM429.USD","LU0354030438.USD","LU2491050154.USD","SGXZ99366536.SGD","LU0080751232.USD","IE00BJLML261.HKD","BK4581","LU2452424414.USD","LU2213496289.HKD","LU1934455863.HKD","BK4532","HK0000320264.USD","LU1815336760.USD","IE00B3M56506.USD","LU2065170008.USD","LU0210528500.USD","LU0124676726.USD","LU2106854487.HKD","LU2552382215.SGD","LU0444973449.USD","BK4543","LU0127658192.USD","LU0964807845.USD","LU2505996509.AUD","LU1852331112.SGD","LU1983260115.SGD","LU1629891620.HKD","LU1496350171.SGD","LU2471134796.USD","SG9999000418.SGD","LU0096362180.USD","LU1571399168.USD","LU1778281490.HKD","LU0061474960.USD","LU0198837287.USD","LU0276348264.USD","SGXZ31699556.SGD","LU2430703251.USD","LU2168564495.EUR","LU0353189680.USD","SG9999015952.SGD","LU2461242641.AUD","IE000W1ABFV2.USD","LU0345769128.USD","LU0077335932.USD","LU0310799852.SGD","IE00BHPRN162.USD","SG9999002232.USD","SG9999014567.USD","IE0004445015.USD","LU1674673691.USD","LU2272731865.HKD","LU2244417387.USD","LU2471134952.CNY","LU0211327993.USD","LU0786609619.USD","LU1989772840.SGD","LU1084165304.USD","LU1720051108.HKD","IE00BJJMRY28.SGD","LU1718418525.SGD","SG9999014898.SGD","LU2077746001.SGD","LU1127390331.HKD","LU1244550494.USD","LU1244550221.USD","BK4503","LU1861127337.USD","LU0957808578.USD","BK4548","LU2931357623.SGD","LU0289960550.SGD","LU2247934214.USD","LU0985320562.USD","LU0048584097.USD","LU2191332357.HKD","LU1037948541.HKD","LU2286300806.USD","LU2462157665.USD","LU0788109477.HKD","SGXZ23171101.USD","LU1551013342.USD","LU0965509010.AUD","LU0787776722.HKD","LU0354030511.USD","IE00BFSS8Q28.SGD","LU0203201768.USD","LU0390134368.USD","LU2097344431.USD","LU2322448957.HKD","LU1989764748.USD","IE00B19Z9505.USD","IE00BK4W5L77.USD","LU1974910355.USD","LU2237438978.USD","LU0965509101.SGD","LU1366192091.USD","NVD","LU0210536198.USD","BK4008","TROW","LU2294711713.HKD","LU2413666426.HKD","LU2552382132.HKD","LU1267930490.SGD","LU0094547139.USD","IE00BMPRXN33.USD","LU0672654240.SGD","LU0417517546.SGD","BK4533","LU1815333072.USD","LU2543165471.USD","LU1267930573.SGD","LU0316494557.USD","LU0265550946.USD","LU2237957902.USD","LU2756315664.SGD","LU1803068979.SGD","LU2505996681.GBP","LU2381873111.SGD","IE00BMPRXQ63.HKD","BK4567","LU2463028550.USD","BK4587","LU0234572021.USD","SG9999014542.SGD","LU2896262040.SGD","LU1119994496.HKD","LU1035775433.USD","LU0820561818.USD","SNVD.UK","IE00BZ199S13.USD","LU0158827781.USD","LU1992135472.HKD","LU0942090050.USD","LU0203202063.USD","LU1951198990.SGD","LU1935043023.USD","LU2168564065.EUR","LU0868494708.USD","LU1366333091.USD","LU0708994859.HKD","LU0342679015.USD","SG9999014906.USD","BK4612","LU0310800379.SGD","SG9999015341.SGD","LU0557290698.USD","LU0096364046.USD","IE0001KFT4U8.USD","LU0823421416.USD","LU1064131342.USD","LU0061474705.USD","LU2125909593.SGD","LU2236285917.USD","IE00B4JS1V06.HKD","LU0957791311.USD","LU2168563687.JPY","LU0106261372.USD","LU1551013425.SGD","LU1496350502.SGD","DD","LU0724617625.USD","SG9999002224.SGD","LU2471134879.HKD","LU1712237335.SGD","LU1116320901.HKD","LU2361044949.HKD","LU2242649171.HKD","LU2473716301.USD","SGXZ51526630.SGD","IE00BN29S564.USD","LU1720051017.SGD","LU2065171311.SGD","LU2023250330.USD","LU2272731782.SGD","LU0689472784.USD","ALK","LU0107464264.USD","HK0000306685.HKD","LU0353189763.USD","LU1868836914.USD","LU2361044865.SGD","SG9999017495.SGD","LU2087625088.SGD","IE00BMPRXR70.SGD"],"gpt_icon":0},{"id":"2590505982","title":"FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats up","url":"https://stock-news.laohu8.com/highlight/detail?id=2590505982","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590505982?lang=en_us&edition=fundamental","pubTime":"2025-12-12 20:04","pubTimestamp":1765541041,"startTime":"0","endTime":"0","summary":"FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats upChanges dateline, adds new details in paragraph 19, 20, 27, 36 and 54. The weight-loss drug market is booming, with biotech firms racing to secure their place in a lucrative sector currently dominated by Novo Nordisk NOVOb.CO and Eli Lilly LLY.N.Analysts project the industry could rake in $150 billion in annual sales by the next decade.Soaring demand for its obesity treatment has helped Lilly become the first pharmaceutical company to reach","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL4N3XI0R0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","600196","LU1323610961.USD","LU0130517989.USD","SG9999002224.SGD","MRK","LU1989772840.SGD","LU2106854487.HKD","LLY","BK0187","SG9999015986.USD","BK4566","LU1035775433.USD","LU0306806265.USD","LU0823434583.USD","IE00BK4W5M84.HKD","LU1720051017.SGD","00656","ALT","VKTX","LU1003077747.HKD","LU0106261372.USD","IE00BJJMRX11.SGD","IE00B4JS1V06.HKD","LU0345777147.USD","IE00BJLML261.HKD","OPK","03933","LU1061106388.HKD","03692","SG9999014906.USD","AMGN","LU0499090636.EUR","SGXZ99366536.SGD","SRRK","IE0005OL40V9.USD","LU0964806797.USD","SG9999013999.USD","IE0002141913.USD","LU0256863902.USD","02105","03165","BK0188","MTSR","LU1989771016.USD","GPCR","IE00BN8TJ469.HKD","AZN.UK","LU0211328371.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":7,"pageCount":3,"totalSize":126,"code":"91000000","status":"200"}]}}